United States · FDA National Drug Code directory
Cytarabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68083-337_b913ae17-4b11-4748-a883-eba1bc9e9c06
- Product NDC
- 68083-337
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Cytarabine
- Labeler
- Gland Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191223
- Source listing expiry
- 20261231
Source-listed ingredients
- CYTARABINE — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-337-01) / 20 mL in 1 VIAL, SINGLE-DOSE · 68083-337-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →